Hospital Universitari de Bellvitge
Also known as: Cancer Epidemiology Research Program (PREC), Catalan Institute of Oncology (ICO-Hospitalet)/Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain. | Daniel Podzamczer | Gynaecology Unit, Bellvitge University Hospital (HUB), L'Hospitalet del Llobregat, Spain. | Hospital Universitari de Bellvitge - Angiology and Vascular Surgery Department | Hospital Universitario de Bellvitge | Isabel Lopez Zamora | José María Piulats Rodríguez | Josep Maria Ramon Torrell, PhD | Josep m Cruzado | M. Carmen Cabellos Minguez | Miguel Santín | Núria Sabé Fernàndez | Sebastian Videla | Unidad de Trasplante Renal - Hospital Universitari de Bellvitge
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2006Last known activity
Jul 31, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (19 distinct, 12 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT05334706Overall official - principal investigatorPhase 2Jul 31, 2022
- NCT05334706Overall official - principal investigatorPhase 2Jul 31, 2022
- NCT05021731Lead sponsorPhase 4Apr 1, 2022
- NCT05047276Lead sponsorPhase 1/Phase 2Oct 1, 2021
- NCT04978051Lead sponsorPhase 2Apr 12, 2021
- NCT05109455Overall official - principal investigatorPhase 4Apr 16, 2019
- NCT01450410Lead sponsorPhase 4Jul 1, 2012
- NCT01581853Lead sponsorPhase 4May 1, 2012
- NCT01538394Lead sponsorPhase 4Jan 1, 2012
- NCT01478035Lead sponsorPhase 4Nov 1, 2011
- NCT01561404Lead sponsorPhase 4Sep 1, 2011
- NCT01178450Lead sponsorPhase 4Jan 1, 2010
- NCT00396721Lead sponsorPhase 2Jan 1, 2006
Details
- Last known activity
- Jul 31, 2022